Well, guess how you can connect with ResearchGate, right through the home page? Facebook (FB).
Beyond using the larger company's database to expand their own reach, however, the two companies have little in common. Anyone can join Facebook. ResearchGate members have to be vetted through the publication of papers.
ResearchGate is newsworthy today because Bill Gates joined its latest $35 million Series C funding round, alongside Tenaya Capital and two other funds,
according to TechCrunch .
Competitor Academia.edu, which also coordinates data through Facebook, actually has more members, almost 3.4 million, against ResearchGate's 2.9 million, but it has only gone through a Series A funding round of $4.5 million. Both companies prefer to be compared with LinkedIn (LNKD).
The two also define their markets somewhat differently -- Academia.edu encourages the sharing of raw data and is open to all academics, while ResearchGate claims it already has half the world's scientific researchers on its membership roles. What's most exciting is how sites like ResearchGate encourage global collaboration among members. Two examples from today's news:
ReadWrite noted the grad student in the Phillippines who posted his failed formula for getting energy from waste oil on the site, then a Spanish scientist
found a tweak that made the formula work.
AllThingD writes about how an Italian researcher with equipment but no samples met a Nigerian with samples but no equipment on the site, and how they've published papers about a new, deadly form of yeast
on ResearchGate itself.
The point for Gates, and for some of the other big-name backers of ResearchGate, is to reduce friction among researchers, encourage collaboration and speed breakthroughs. The old world of peer-reviewed research that costs thousands to publish and access is giving way to a more open and collaborative process. Whether this model can get its discoveries through the maze of "intellectual property" laws and into the market is still open to debate.
At the time of publication the author had no position in any of the stocks mentioned. Follow @DanaBlankenhorn This article was written by an independent contributor, separate from TheStreet's regular news coverage.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV